New Drug Approved for All Cancers With Genetic Marker

TUESDAY, May 23, 2017 — Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat any cancer that has a certain genetic biomarker, regardless of where in the body the cancer originated.
“This is an important first…
Source: Topamax